1110 - Why has Utilization of Novel Gram-negative Antibiotics been Sluggish in U.S. Hospitals? A Retrospective Cohort Study to Inform Future Antibiotic Development and Market Entry Rewards

Co-Author(s)

• JS

  Jeffrey R. Strich, MD

  Staff Clinician
  Clinical Center, National Institutes of Health
  Bethesda, Maryland, United States

Co-Author(s)

• AM

  Ahmed Ullah Mishuk, PhD

  Post Doc
  Critical Care Medicine Department, National Institutes of Health Clinical Center
  Bethesda, Maryland, United States

Co-Author(s)

• AL

  Alexander Lawandi, MD

  1. Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD
  Montreal, Quebec, Canada
• GD

  Guoqing Diao, PhD

  Professor
  George Washington University Milken Institute School of Public Health
  Washington, District of Columbia, United States
• SW

  Sarah Warner, MPH

  Senior Data Manager
  Critical Care Medicine, National Institutes of Health Clinical Center
  Bethesda, Maryland, United States
• WL

  Willy Li, Pharm D

  1. Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, 4. Department of Pharmacy, Clinical Center, National Institutes of Health, Bethesda, MD
  Bethesda, Maryland, United States
• CD

  Cumhur Y. Demirkale, PhD

  Statistician
  National Institutes of Health
  Bethesda, MD, United States
• AM

  Alex Mancera, MS

  1. Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, 2. Critical Care Medicine Branch, National Heart Lung and Blood Institute, Bethesda, MD
  Bethesda, Maryland, United States

Presenting Author(s)

• 

  Morgan Walker, MD (she/her/hers)

  Clinical Fellow
  Critical Care Medicine Department, Clinical Center, National Institutes of Health, Critical Care Medicine Branch, National Heart Lung and Blood Institute
  Bethesda, MD, United States

  Slides

Co-Author(s)

• 

  Christina Yek, MD

  Clinical Fellow
  National Institute of Allergy and Infectious Diseases
  Bethesda, Maryland, United States
• MN

  Maniraj Neupane, MD, PhD

  1. Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, 2. Critical Care Medicine Branch, National Heart Lung and Blood Institute, Bethesda, MD
  Bethesda, Maryland, United States
• ND

  Nathaniel De Jonge, BA

  1. Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, 2. Critical Care Medicine Branch, National Heart Lung and Blood Institute, Bethesda, MD
  Bethesda, Maryland, United States
• 

  Sameer S. Kadri, MD, MS, FIDSA

  Intensivist and Head, Clinical Epidemiology Section, Critical Care Medicine Department
  National Institutes of Health Clinical Center
  Bethesda, Maryland, United States